{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:27:10Z","timestamp":1786793230078,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007534","name":"B Braun SE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007535","name":"B. Braun Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007535","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.carrev.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:50:21Z","timestamp":1786492221000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-coated balloon (SeQuent please neo) versus drug-eluting stent treatment for acute ST-elevation myocardial infarction: Design and rationale of the STEMI DCB trial"],"prefix":"10.1016","author":[{"given":"Christopher J.","family":"Broyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cockburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Bagnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abouelasaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.","family":"Langrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rawlins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Eccleshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hildick-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2026.08.003_bb0005","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jacc.2020.12.059","article-title":"10-year follow-up of patients with Everolimus-eluting versus bare-metal stents after ST-segment elevation myocardial infarction","volume":"77","author":"Brugaletta","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-related adverse events >1 year after percutaneous coronary intervention","volume":"75","author":"Madhavan","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2023.01.007","article-title":"Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: design and rationale of the SELUTION DeNovo Trial","volume":"258","author":"Spaulding","year":"2023","journal-title":"Am. Heart J."},{"key":"10.1016\/j.carrev.2026.08.003_bb0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jcin.2020.12.005","article-title":"Stent thrombosis risk over time on the basis of clinical presentation and platelet reactivity: analysis from ADAPT-DES","volume":"14","author":"Chau","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0025","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","article-title":"Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial","volume":"371","author":"Wiviott","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2026.08.003_bb0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jacc.2013.10.022","article-title":"Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX trial","volume":"63","author":"G\u00e9nereux","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1160\/TH06-08-0479","article-title":"Active endothelin is an important vasoconstrictor in acute coronary thrombi","volume":"97","author":"Adlbrecht","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.carrev.2026.08.003_bb0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.biopha.2009.06.004","article-title":"Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models","volume":"63","author":"Di Stefano","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.carrev.2026.08.003_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4244\/EIJY15M11_01","volume":"11","author":"Nakatani","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.003_bb0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry","volume":"53","author":"van Werkum","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ahj.2014.05.018","article-title":"Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations","volume":"168","author":"Loh","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.carrev.2026.08.003_bb0070","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"HEAT-PPCI trial investigators. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2026.08.003_bb0075","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jcin.2023.01.380","article-title":"Assessment of paclitaxel drug-coated balloon only angioplasty in STEMI","volume":"16","author":"Merinopoulos","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0080","series-title":"Audit Results [Internet]","author":"British Cardiovascular Intervention Society","year":"2025"},{"key":"10.1016\/j.carrev.2026.08.003_bb0085","series-title":"Drug-Coated Balloons","first-page":"151","article-title":"Drug-coated balloons in STEMI","author":"Wickramarachchi","year":"2018"},{"key":"10.1016\/j.carrev.2026.08.003_bb0090","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0095","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.003_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcin.2013.07.012","article-title":"Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION and COMFORTABLE-AMI trials","volume":"7","author":"Sabat\u00e9","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0105","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2026.08.003_bb0110","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"G\u00f6tberg","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2026.08.003_bb0115","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0140-6736(18)32283-9","article-title":"Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial","volume":"392","author":"Stone","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2026.08.003_bb0120","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting Bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2026.08.003_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jacc.2020.05.026","article-title":"10-year outcomes from a randomized trial of polymer-free versus durable polymer drug-eluting coronary stents","volume":"76","author":"Kufner","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199610243351701","article-title":"A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction","volume":"335","author":"Every","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2026.08.003_bb0135","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1997.03550230069040","article-title":"Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review","volume":"278","author":"Weaver","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2026.08.003_bb0140","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/CIRCINTERVENTIONS.113.000415","article-title":"Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction","volume":"6","author":"Bangalore","year":"2013","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0145","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.jacc.2019.09.038","article-title":"Efficacy and safety of stents in ST-segment elevation myocardial infarction","volume":"74","author":"Chichareon","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0150","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction","volume":"360","author":"Stone","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.carrev.2026.08.003_bb0155","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.2012.10065","article-title":"Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial","volume":"308","author":"R\u00e4ber","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2026.08.003_bb0160","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehm402","article-title":"Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction","volume":"28","author":"Kastrati","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.carrev.2026.08.003_bb0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/joic.12082","article-title":"Very late hazard with stenting versus balloon angioplasty for ST-elevation myocardial infarction: a 16-year single-center experience","volume":"27","author":"Brodie","year":"2014","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016224","article-title":"Clinical and angiographic outcomes with drug-coated balloons for de novo coronary lesions: a meta-analysis of randomized clinical trials","volume":"9","author":"Elgendy","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.carrev.2026.08.003_bb0175","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2026.08.003_bb0180","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus Everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0190","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","article-title":"Treatment of coronary drug-eluting stent restenosis by a Sirolimus- or paclitaxel-coated balloon","volume":"12","author":"Ali","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0195","first-page":"1919","article-title":"Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX RCT","volume":"13","author":"Jensen","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.003_bb0200","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2017.04.024","article-title":"Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial","volume":"10","author":"Kufner","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0205","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","volume":"59","author":"Rittger","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4244\/EIJV9I5A98","article-title":"Drug-coated balloons for de novo coronary lesions: results from the valentines II trial","volume":"9","author":"Waksman","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.003_bb0215","first-page":"181","article-title":"Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: the DCB-only all-comers registry","volume":"93","author":"Rosenberg","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0220","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2459\/JCM.0000000000000806","article-title":"Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry","volume":"20","author":"Cortese","year":"2019","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.carrev.2026.08.003_bb0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty","volume":"104","author":"Kleber","year":"2015","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.126.079033","article-title":"SELUTION DeNovo investigators. Sirolimus-eluting balloon with provisional stenting versus systematic drug-eluting stent implantation to treat De novo coronary lesions: a randomized, open-label, noninferiority trial","author":"Spaulding","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2026.08.003_bb0235","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4244\/EIJV10I5A101","article-title":"Safety and feasibility of a paclitaxel-eluting balloon angioplasty in primary percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study","volume":"10","author":"Vos","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2026.08.003_bb0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4330\/wjc.v7.i6.311","article-title":"Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention","volume":"7","author":"Ho","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.carrev.2026.08.003_bb0245","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION trial","volume":"12","author":"Vos","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2026.08.003_bb0250","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2306203","article-title":"Comparison of drug-coated balloons and drug-eluting stents in primary percutaneous coronary interventions for ST-segment elevated myocardial infarction: a systematic review and meta-analysis","volume":"23","author":"Su","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.carrev.2026.08.003_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd10010029","article-title":"Comparisons of drug-eluting balloon versus drug-eluting stent in the treatment of young patients with acute myocardial infarction","volume":"10","author":"Yang","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.carrev.2026.08.003_bb0260","article-title":"Reduced stent strategy versus conventional percutaneous coronary revascularization in patients presenting with STEMI: design of the COPERNICAN trial","volume":"79","author":"Sanz-S\u00e1nchez","year":"2025","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"key":"10.1016\/j.carrev.2026.08.003_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2026.107463","article-title":"The European bifurcation club randomized trial of stepwise provisional stenting vs drug-coated balloon therapy for nonleft main true coronary bifurcations: The EBC DCB trial","author":"Broyd","year":"2026","journal-title":"Am. Heart J."}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838926003386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838926003386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:15:35Z","timestamp":1786792535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838926003386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S1553838926003386"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2026.08.003","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-coated balloon (SeQuent please neo) versus drug-eluting stent treatment for acute ST-elevation myocardial infarction: Design and rationale of the STEMI DCB trial","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}